期刊文献+

高场MR中含钆对比剂优化使用研究进展 被引量:2

Update on the optimal use of gadolinium-based contrast agents at high field MR
下载PDF
导出
摘要 1998年前后,主要的MR生产厂家开始推出高场全身MR扫描仪,其中以3Tesla(T)为代表[1]。随着场强不断增加的同时,MRI含钆对比剂也得到了迅速发展,先后出现了离子型、非离子型细胞外对比剂及肝细胞特异性对比剂等。在由低场向高场应用转变中,磁敏感效应加大,随着组织T1驰豫时间不断延长,增强扫描时钆对比剂剂量将如何变化?不同部位的选择有无差异?不同序列又该做何调整?本文将对上述问题相关研究做一综述,以期指导临床优化使用含钆对比剂。 Since approximately 1998, the major MR scanner manufacturers have begun to offer high field whole body scanners, typieally operating at 3.0 T. With the inerease in static magnetic field strength, more and more gadolinlum-based MRI contrast agents were introduced into the elirtieal environment, e.g. ionic and nonionie extracellular contrast agent and hepatocyte-selective contrast agents. The higher the smile magnetic field strength, the stronger the susceptibility effects. With an increase in the T1 relaxation time, what are the optimal doses in routine clinieal applieailons what dose of contrast agents will offer the best enhancement in different location and improve advanced MR speeialized teehniques? This article will provide an overview of these above mentioned questions.
作者 郭丽君 柳澄
出处 《医学影像学杂志》 2010年第1期128-131,共4页 Journal of Medical Imaging
关键词 高场磁共振 含钆对比剂 优化使用 High field MR Gadolinium-based contrast agents Optimal use
  • 相关文献

参考文献25

  • 1Frayne R, Goodyear BG, DickhoffP, et al. Magnetic resonance imaging at 3.0 tesla: challenges and advantages in clinical neurological imaging [J]. Invest Radiol, 2003, 38:385 -402.
  • 2de Haen C. Conception of the first magnetic resonance imaging contrast agents: a brief history [J]. Top Magn Resort Imaging, 2001, 12:221 - 230.
  • 3Kuo PH, Kanal E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis [J]. Radiology, 2007, 242: 647-649.
  • 4Tanenbaum LN. 3 - T MR imaging: ready for clinical practice [J]. AJNR, 2004,25: 1626- 1627.
  • 5Ethofer T, Matter I, Seeger U, et al. Comparison of longitudinal metabollte relaxation times in different regions of the human brain at 1.5 and 3 tesla [J]. Magn Reson Med, 2003, 50: 1296-1301.
  • 6de Bazelaire CM, Duhamel GD, Rofsky NM, et al. MR imaging relaxation times of alxlominal and pelvic tissues measured in vivo at 3.0 T: preliminary results [J]. Radiology, 2004, 230: 652- 659.
  • 7Bleicher AG, Kanal E. A serial dilution study of gadolinium-based MR imaging contrast agents [J].AJNR, 2007, 29: 668-673.
  • 8Akeson P, Vikboff B, Stahlberg F, et al. Brain lesion contrast in MR imaging: dependence of field strength and concentration of gadodiamide injection in patients and phantoms [J]. Acta Radiol, 1997, 38: 14- 18.
  • 9Chang KH, Ra DG, Han MH, et al. Contrast enhancement of brain tumouts at different MR field strengths, comparison of 0.5 T and 2.0 T [J]. AJNR, 1994, 15 : 1413-1419.
  • 10Haustein J, Laniado M, Niondoff HP, et al. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumours: dosage and field strength [J]. AJNR, 1992, 13: 1199- 1206.

二级参考文献32

  • 1Laissy JP, Assayag P, Henry-Feugeas MC, et al. Pulmonary time-of-flight MR angiography at 1.0 T: comparison between 2D and 3D tone acquisitions. Magn Reson Imaging, 1995, 13: 949-957.
  • 2Prince MR, Grist TM, Debatin JF, eds. 3D contrast MR angiography. Germany: Springer,1999.3-52.
  • 3Goodman LR, Curtin JJ, Mewissen MW, et al. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography. AJR, 1995,164:1369-1374.
  • 4Remy-Jardin M, Remy J, Deschildre F, et al. Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology, 1996, 200:699-706.
  • 5Teigen CL, Maus TP, Sheedy PF 2nd, et al. Pulmonary embolism:diagnosis with contrast-enhanced electron-beam CT and comparison with pulmonary angiography. Radiology, 1995,194:313-319.
  • 6Loubeyre P, Revel D, Douek P, et al. Dynamic contrast-enhanced MR angiography of pulmonary embolism: comparison with pulmonary angiography. AJR, 1994, 162: 1035-1039.
  • 7Meaney JF, Prince MR. Pulmonary MR angiography. Magn Reson Imaging Clin N Am, 1999, 7: 393-409.
  • 8Gupta A, Frazer CK, Ferguson JM, et al. Acute pulmonary embolism: diagnosis with MR angiography. Radiology, 1999,210: 353-359.
  • 9Lentschig MG, Reimer P, Rausch-Lentschig UL, et al. Breath-hold gadolinium-enhanced MR angiography of the major vessels at 1.0 T: dose-response findings and angiographic correlation. Radiology, 1998, 208: 353-357.
  • 10Alley MT, Shifrin RY, Pelc NJ, et al. Ultrafast contrast-enhanced three-dimensional MR angiography: state of the art. Radiographics, 1998, 18:273-285.

共引文献1

同被引文献2

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部